Partner

2001 K Street, NW
District of Columbia, 20006-1047
United States

+1-202-223-7455

40 & Under List


Practice area:

Commercial
Securities


Lina Dagnew is a partner in the Paul, Weiss Litigation Department. She is a trial lawyer who represents domestic and international clients in high-stakes disputes involving complex commercial litigation, sensitive internal investigations, white collar defense, employment, and Foreign Corrupt Practices Act matters. Lina regularly advises and represents financial institutions across a spectrum of matters, and has previously served as in-house counsel at one of the largest financial institutions. Lina also routinely represents companies and board members in M&A-related litigation in state and federal courts. Lina has jury trial experience in state and federal courts, and is well versed in all stages of critical litigation.

Lina also maintains an active pro bono practice and has successfully represented clients in civil and criminal matters as well as in administrative proceedings. She serves on the board of the Urban Justice Center, an organization that incubates and accelerates early-stage social justice organizations. She is also a contributing author to the Anti-Bribery and Anti-Corruption Review, U.S. Chapter. During law school, Lina was a member of the Harvard Legal Aid Bureau, providing direct legal representation to vulnerable clients across legal issues

  • Citigroup in multiple complex commercial litigation matters in state and federal courts on variable rate debt obligations, including an antitrust class action and state-specific false claims act cases.

  • Citibank in the successful dismissal of a qui tam action brought under the Florida False Claims Act in connection with synthetic fixed-rate transactions with a notional value of $1 billion.

  • A leading pharmaceutical company in litigation matters, including a putative class action, brought principally by insurance companies.

  • The New York State Unified Court System in litigations in state and federal courts regarding the COVID-19 vaccine mandates for employees, nearly all of which have been successfully dismissed.

  • The special committee of the board of directors of QAD Inc., a leading provider of cloud-based enterprise software solutions, in a stockholder’s preliminary injunction motion in the Delaware Court of Chancery seeking to block a shareholder vote on QAD’s $2 billion merger with private equity firm Thoma Bravo and subsequent litigation.

  • Class action
  • Commercial disputes
  • Competition/antitrust
  • Dispute resolution
  • Government and regulatory
  • Labor and employment
  • White collar crime
  • Anti-Corruption & FCPA
  • Litigation
  • Mergers & Acquisitions Litigation
  • False Claims Act & Qui Tam

  • J.D. - Harvard Law School
  • B.A. - Manchester University
     

  • District of Columbia
  • New York